Nanopore analysis of the interaction of metal ions with prion proteins and peptides

Biochemistry and Cell Biology

Volumn 88, Issue 2, 2010, Pages 347-358

  Stefureac, Radu I ^a   Madampage, Claudia Avis ^a   Andrievskaia, Olga ^b   Lee, Jeremy S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

Metal ion binding; Nanopores; Prion protein; Protein folding; hemolysin

Indexed keywords

BLOOD; COMPLEXATION; CONFORMATIONS; MANGANESE; MANGANESE COMPOUNDS; METAL ANALYSIS; METAL IONS; METALS; MOLECULES; PEPTIDES; PROTEIN FOLDING; ZINC; ZINC COMPOUNDS;

APPLIED VOLTAGES; COMPLEX FORMATIONS; CONFORMATIONAL CHANGE; DIVALENT METAL ION; HIGH CONCENTRATION; METAL ION BINDING; PRION PROTEIN; PROTEIN MOLECULES;

NANOPORES;

ALPHA HEMOLYSIN; COPPER; MAGNESIUM; MANGANESE; METAL ION; PRION PROTEIN; RECOMBINANT PROTEIN; ZINC; ION; METAL; NANOMATERIAL; PEPTIDE; PRION;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; LIGAND BINDING; METAL BINDING; NANOPORE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; STRUCTURE ANALYSIS; ANIMAL; BOVINAE; CHEMICAL STRUCTURE; CHEMISTRY; NANOTECHNOLOGY; PRION;

BOVINAE;

ANIMALS; CATTLE; IONS; METALS; MODELS, MOLECULAR; NANOSTRUCTURES; NANOTECHNOLOGY; PEPTIDES; PRIONS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

EID: 77950616187     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O09-176     Document Type: Conference Paper

References (55)

1. Andrievskaia, O., McRae, H., Elmgren, C., Huang, H., Balachandran, A., and Nielsen, K. 2006. Generation of antibodies against bovine recombinant prion protein in various strains of mice. Clin. Vaccine Immunol. 13(1): 98-105. doi:10.1128/CVI.13.1. 98-105.2006. PMID:16426006.
2. Bashford, C.L., Alder, G.M., Graham, J.M., Menestrina, G., and Pasternak, C.A. 1988. Ion modulation of membrane permeability: effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents. J. Membr. Biol. 103(1): 79-94. doi:10.1007/BF01871934. PMID:2846846.
3. Bennion, B.J., DeMarco, M.L., and Daggett, V. 2004. Preventing misfolding of the prion protein by trimethylamine N-oxide. Biochemistry, 43(41): 12955-12963. doi:10.1021/bi0486379. PMID: 15476389.
4. Brazier, M.W., Davies, P., Player, E., Marken, F., Viles, J.H., and Brown, D.R. 2008. Manganese binding to the prion protein. J. Biol. Chem. 283(19): 12831-12839. doi:10.1074/jbc.M709820200. PMID:18332141.
5. Burns, C.S., Aronoff-Spencer, E., Legname, G., Prusiner, S.B., Antholine, W.E., Gerfen, G.J., et al. 2003. Copper coordination in the full-length, recombinant prion protein. Biochemistry, 42(22): 6794-6803. doi:10.1021/ bi027138+. PMID:12779334.
6. Sc replication in vitro generates unique infectious prions. Cell, 134(5): 757-768. doi:10.1016/j.cell.2008.07.030. PMID:18775309.
7. Caughey, B., and Baron, G.S. 2006. Prions and their partners in crime. Nature, 443(7113): 803-810. doi:10.1038/nature05294. PMID:17051207.
8. Chien, P., Weissman, J.S., and DePace, A.H. 2004. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73(1): 617-656. doi:10.1146/annurev.biochem.72.121801.161837. PMID:15189155.
9. Chiti, F., and Dobson, C.M. 2006. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75(1): 333-366. doi:10.1146/annurev. biochem.75.101304.123901. PMID: 16756495.
10. Cobb, N.J., and Surewicz, W.K. 2009. Prion diseases and their biochemical mechanisms. Biochemistry, 48(12): 2574-2585. doi:10.1021/bi900108v. PMID:19239250.
11. Collinge, J., and Clarke, A.R. 2007. A general model of prion strains and their pathogenicity. Science, 318(5852): 930-936. doi:10.1126/science.1138718. PMID:17991853.
12. Croes, E.J., Theuns, J., Houwing-Duistermaat, J.J., Dermaut, B., Sleegers, K., Roks, G., et al. 2004. Octapeptide repeat insertions in the prion protein gene and early onset dementia. J. Neurol. Neurosurg. Psychiatry, 75(8): 1166-1170. doi:10.1136/jnnp.2003.020198.
13. Dekker, C. 2007. Solid-state nanopores. Nature, 2: 209-215.
14. Deleault, N.R., Lucassen, R.W., and Supattapone, S. 2003. RNA molecules stimulate prion protein conversion. Nature, 425(6959): 717-720. doi:10.1038/nature01979. PMID:14562104.
15. Gaggelli, E., Bernardi, F., Molteni, E., Pogni, R., Valensin, D., Valensin, G., et al. 2005. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies. J. Am. Chem. Soc. 127(3): 996-1006. doi:10.1021/ja045958z. PMID:15656638.
16. Gaggelli, E., Kozlowski, H., Valensin, D., and Valensin, G. 2006. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem. Rev. 106(6): 1995-2044. doi:10.1021/cr040410w. PMID:16771441.
17. Goldfarb, L.G., Brown, P., McCombie, W.R., Goldgaber, D., Swergold, G.D., Wills, P.R., et al. 1991. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Prc. Natl. Acad. Sci. 88(23): 10926-10930. doi:10.1073/pnas.88.23. 10926.
18. Goodrich, C.P., Kirmizialtin, S., Huyghues-Despointes, B.M., Zhu, A., Scholtz, J.M., Makarov, D.E., and Movileanu, L. 2007. Single-molecule electrophoresis of beta-hairpin peptides by electrical recordings and Langevin dynamics simulations. J. Phys. Chem. B, 111(13): 3332-3335. doi:10.1021/ jp071364h. PMID: 17388500.
19. Gu, L.Q., Cheley, S., and Bayley, H. 2001. Prolonged residence time of a noncovalent molecular adapter, β-cyclodextrin, within the lumen of mutant α-hemolysin pores. J. Gen. Physiol. 118(5): 481-494. doi:10.1085/jgp.118. 5.481. PMID:11696607.
20. Heins, E.A., Siwy, Z.S., Baker, L.A., and Martin, C.R. 2005. Detecting single porphyrin molecules in a conically shaped synthetic nanopore. Nano Lett. 5(9): 1824-1829. doi:10.1021/nl050925i. PMID:16159231.
21. Hurt, N., Wang, H., Akeson, M., and Lieberman, K.R. 2009. Specific nucleotide binding and rebinding to individual DNA polymerase complexes captured on a nanopore. J. Am. Chem. Soc. 131(10): 3772-3778. doi:10.1021/ja809663f. PMID:19275265.
22. Jobling, M.F., Huang, X., Stewart, L.R., Barnham, K.J., Curtain, C., Volitakis, I., et al. 2001. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry, 40(27): 8073-8084. doi:10.1021/bi0029088. PMID:11434776.
23. Leach, S.P., Salman, M.D., and Hamar, D. 2006. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein. Anim. Health Res. Rev. 7(1/2): 97-105.
24. Leliveld, S.R., Dame, R.T., Wuite, G.J.L., Stitz, L., and Korth, C. 2006. The expanded octarepeat domain selectively binds prions and disrupts homomeric prion protein interactions. J. Biol. Chem. 281(6): 3268-3275. doi:10.1074/jbc.M510606200. PMID:16352600.
25. Lima, L.M.T.R., Cordeiro, Y., Tinoco, L.W., Marques, A.F., Oliveira, C.L.P., Sampath, S., et al. 2006. Structural insights into the interaction between prion protein and nucleic acid. Biochemistry, 45(30): 9180-9187. doi:10.1021/bi060532d. PMID: 16866364.
26. Makarov, D.E. 2009. Computer simulations and theory of protein translocation. Acc. Chem. Res. 42(2): 281-289. doi:10.1021/ar800128x.
27. Marc, D., Mercey, R., and Lantier, F. 2007. Scavenger, transducer, RNA chaperone? What ligands of the prion protein teach us about its function. Cell. Mol. Life Sci. 64(7-8): 815-829. doi:10.1007/s00018-007-6370-1. PMID:17256089.
28. Menestrina, G. 1986. Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J. Membr. Biol. 90(2): 177-190. doi:10.1007/BF01869935. PMID:2425095.
29. Millhauser, G.L. 2004. Copper binding in the prion protein. Acc. Chem. Res. 37(2): 79-85. doi:10.1021/ar0301678. PMID:14967054.
30. Mohammad, M.M., and Movileanu, L. 2008. Excursion of a single polypeptide into a protein pore: simple physics, but complicated biology. Eur. Biophys. J. 37(6): 913-925. doi:10.1007/s00249-008-0309-9. PMID:18368402.
31. Mohammad, M.M., Prakash, S., Matouschek, A., and Movileanu, L. 2008. Controlling a single protein in a nanopore through electrostatic traps. J. Am. Chem. Soc. 130(12): 4081-4088. doi:10. 1021/ja710787a. PMID:18321107.
32. Morante, S., González-Iglesias, R., Potrich, C., Meneghini, C., Meyer-Klaucke, W., Menestrina, G., and Gasset, M. 2004. Inter-and intra-octarepeat Cu(II) site geometries in the prion protein: implications in Cu(II) binding cooperativity and Cu(II)-mediated assemblies. J. Biol. Chem. 279(12): 11753-11759. doi:10.1074/jbc.M312860200. PMID:14703517.
33. Morillas, M., Vanik, D.L., and Surewicz, W.K. 2001. On the mechanism of α-helix to β-sheet transition in the recombinant prion protein. Biochemistry, 40(23): 6982-6987. doi:10.1021/bi010232q. PMID:11389614.
34. Movileanu, L., Schmittschmitt, J.P., Scholtz, J.M., and Bayley, H. 2005. Interactions of peptides with a protein pore. Biophys. J. 89(2): 1030-1045. doi:10.1529/biophysj.104.057406. PMID:15923222.
35. Nandi, P.K. 1997. Interaction of prion peptide HuPrP106-126 with nucleic acid. Arch. Virol. 142(12): 2537-2545. doi:10.1007/s007050050261. PMID:9672613.
36. Oukhaled, G., Mathé, J., Biance, A.-L., Bacri, L., Betton, J.-M., Lairez, D., et al. 2007. Unfolding of Proteins and Long Transient Conformations Detected by Single Nanopore Recording. PRL, 98(15): 158101-158104. doi:10.1103/PhysRevLett.98.158101.
37. Prusiner, S.B. 2001. Neurodegenerative diseases and prions. N. Engl. J. Med. 344(20): 1516-1526. doi:10.1056/NEJM200105173442006. PMID:11357156.
38. Quaglio, E., Chiesa, R., and Harris, D.A. 2001. Copper Converts the Cellular Prion Protein into a Protease-resistant Species That Is Distinct from the Scrapie Isoform. J. Biol. Chem. 276(14): 11432-11438. doi:10.1074/jbc. M009666200.
39. Saborio, G.P., Permanne, B., and Soto, C. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 411(6839): 810-813. doi:10.1038/35081095. PMID:11459061.
40. Siwy, Z., Trofin, L., Kohli, P., Baker, L.A., Trautmann, C., and Martin, C.R. 2005. Protein biosensors based on biofunctionalized conical gold nanotubes. J. Am. Chem. Soc. 127(14): 5000-5001. doi:10.1021/ja043910f. PMID:15810817.
41. Stefureac, R.I., and Lee, J.S. 2008. Nanopore analysis of the folding of zinc fingers. Small, 4(10): 1646-1650. doi:10.1002/smll.200800585. PMID:18819138.
42. Stefureac, R., Long, Y.T., Kraatz, H.B., Howard, P., and Lee, J.S. 2006. Transport of α-helical peptides through alpha-hemolysin and aerolysin pores. Biochemistry, 45(30): 9172-9179. doi:10.1021/bi0604835. PMID:16866363.
43. Stefureac, R., Waldner, L., Howard, P., and Lee, J.S. 2008. Nano-pore analysis of a small 86-residue protein. Small, 4(1): 59-63. doi:10.1002/smll. 200700402. PMID:18058890.
44. Stöckel, J., Safar, J., Wallace, A.C., Cohen, F.E., and Prusiner, S.B. 1998. Prion protein selectively binds copper(II) ions. Biochemistry, 37(20): 7185-7193. doi:10.1021/bi972827k. PMID:9585530.
45. Sutherland, T.C., Long, Y.-T., Stefureac, R., Bediako-Amoa, I., Kraatz, H.-B., and Lee, J.S. 2004. Structure of Peptides Investigated by Nanopore Analysis. Nano Lett. 4(7): 1273-1277. doi:10.1021/nl049413e.
46. Thompsett, A.R., and Brown, D.R. 2007. Dual polarisation interferometry analysis of copper binding to the prion protein: evidence for two folding states. Biochim. Biophys. Acta, 1774(7): 920-927. PMID:17573247.
47. Todorova-Balvay, D., Simon, S., Créminon, C., Grassi, J., Srikrishnan, T., and Vijayalakshmi, M.A. 2005. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 818(1): 75-82. doi:10.1016/j.jchromb.2004.10.011. PMID:15722047.
48. 2 concept. Annu Rev Biophys, 37(1): 215-246. doi:10.1146/annurev. biophys.37.032807.125924. PMID:18573080.
49. Varela-Nallar, L., González, A., and Inestrosa, N.C. 2006. Role of copper in prion diseases: deleterious or beneficial? Curr. Pharm. Des. 12(20): 2587-2595. doi:10.2174/138161206777698873. PMID:16842180.
50. Walsh, P., Simonetti, K., and Sharpe, S. 2009. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein. Structure, 17(3): 417-426. doi:10.1016/j.str.2008.12.018. PMID:19278656.
51. Walter, E.D., Chattopadhyay, M., and Millhauser, G.L. 2006. The affinity of copper binding to the prion protein octarepeat domain: evidence for negative cooperativity. Biochemistry, 45(43): 13083-13092. doi:10.1021/bi060948r. PMID:17059225.
52. Wells, M.A., Jackson, G.S., Jones, S., Hosszu, L.L.P., Craven, C.J., Clarke, A.R., et al. 2006. A reassessment of copper(II) binding in the full-length prion protein. Biochem. J. 399(3): 435-444. doi:10.1042/BJ20060458. PMID:16824036.
53. Xu, Y., Oyola, R., and Gai, F. 2003. Infrared Study of the Stability and Folding Kinetics of a 15-Residue β-Hairpin. J. Am. Chem. Soc. 125(50): 15388-15394. doi:10.1021/ja037053b.
54. Zhao, Q., Jayawardhana, D.A., Wang, D., and Guan, X. 2009. Study of peptide transport through engineered protein channels. J. Phys. Chem. B, 113(11): 3572-3578. doi:10.1021/jp809842g. PMID:19231820.
55. Zhu, F., Davies, P., Thompsett, A.R., Kelly, S.M., Tranter, G.E., Hecht, L., et al. 2008. Raman optical activity and circular dichroism reveal dramatic differences in the influence of divalent copper and manganese ions on prion protein folding. Biochemistry, 47(8): 2510-2517. doi:10.1021/bi7022893. PMID:18205409.